|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2025 | 328 GRE | 3.4 | 8 | Finance: Investment Banking | India |
24 May 2025 05:09 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 320 GRE | 4 | Finance: Venture Capital | India |
23 May 2025 06:01 AM
|
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2025 | 685 GMAT Focus | 8.4 | 5 | Technology | India |
08 Apr 2025 02:59 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2025 | 3.6 | 10 | Pharmaceuticals and Biotech | United States |
06 Apr 2025 10:17 PM
|
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2025 | 675 GMAT Focus | 15 | Energy | India |
02 Apr 2025 08:28 AM
|
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2025 | 715 GMAT Focus | 7.2 | 4 | Consulting | India |
01 Apr 2025 10:53 PM
|
| Full Time MBA |
Admitted
|
Round 1 | 2022 | 250 GMAT Classic 780 GMAT Classic 338 GRE |
3 | 5 | Consulting | Kuwait |
01 Apr 2025 10:37 PM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2025 | 327 GRE 331 GRE |
7.3 | 9 | Finance: Investment Banking | India |
01 Apr 2025 11:48 AM
|
| Full Time MBA |
Denied with Interview
|
Round 1 | 2025 | 5 | Finance: Investment Banking | China |
30 Mar 2025 02:13 AM
|
||
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2025 | 327 GRE | 3.2 | 6 | Healthcare/Pharmaceuticals | Canada |
27 Mar 2025 10:47 AM
|
| Full Time MBA |
Denied with Interview
|
Round 1 | 2025 | 770 GMAT Classic | 8.1 | 5 | Finance | United States |
23 Mar 2025 07:31 PM
|
| Full Time MBA |
Denied with Interview
|
Round 1 | 2025 | 710 GMAT Classic | 3.5 | 4 | Consulting | United States |
22 Mar 2025 08:08 AM
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2025 | 745 GMAT Focus | 8.5 | 5 | Consulting | India |
20 Mar 2025 02:15 PM
|
| Full Time MBA |
Admitted, ($)
|
Round 2 | 2025 | 665 GMAT Focus | 3.4 | 7 | Finance: Private Equity | Viet Nam |
20 Mar 2025 07:52 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2025 | 68 | 6 | Consulting | Ghana |
20 Mar 2025 12:40 AM
|
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2025 | 645 GMAT Focus | 6 | Healthcare/Pharmaceuticals | India |
19 Mar 2025 10:15 AM
|
|
| Full Time MBA |
Denied with Interview
|
Round 2 | 2025 | Waiver 635 GMAT Focus |
3.6 | 6 | Energy | India |
19 Mar 2025 09:20 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2025 | 705 GMAT Focus | 7 | Consulting | India |
19 Mar 2025 05:18 AM
|
|
| Full Time MBA |
Admitted
|
Round 2 | 2025 | 755 GMAT Focus | 2.2 | 6 | Government | India |
18 Mar 2025 02:15 PM
|
| Full Time MBA |
Admitted, ($$$$)
|
Round 2 | 2025 | 329 GRE | 68 | 7 | Consulting | India |
18 Mar 2025 12:55 PM
|